Elisabeth Little Sandoval

Ms. Elisabeth A. Sandoval is an Independent Director at PROCEPT BioRobotics Corp.
and an Independent Director at VYNE Therapeutics, Inc. She is on the Board of Directors at PROCEPT BioRobotics Corp.
and VYNE Therapeutics, Inc. Ms. Sandoval was previously employed as an Independent Director by Intersect ENT, Inc., an Independent Director by Satsuma Pharmaceuticals, Inc., an Independent Director by Menlo Therapeutics, Inc., a Chief Commercial Officer & EVP-Corporate Strategy by Alder Biopharmaceuticals, Inc., a Chief Commercial Officer by Kythera Biopharmaceuticals Inc, a Vice President-Global Marketing by Bausch & Lomb BV, a Vice President-Global Marketing by Allergan Ltd. (Ireland), and a Vice President-Marketing by Bausch & Lomb Surgical, Inc. She also served on the board at ALASTIN Skincare, Inc. and Feldan Bio, Inc. She received her undergraduate degree from the University of California, Irvine and an MBA from Pepperdine University.